NovAliX

About:

NovAliX is a company that aids managers, scientists, and project managers with drug discovery projects.

Website: https://novalix.com

Twitter/X: novalix_pharma

Top Investors: Bpifrance, Bruker, Région Grand Est

Description:

NovAliX is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry's outsourcing needs from discovery to manufacturing. With proprietary SPR technology, X-ray protein crystallography, supramolecular mass spectrometry and chemistry, NovAliX offers comprehensive integrated services for small molecule drug discovery. With advanced NMR technologies, NovAliX provides fine characterization of biologics, thorough analysis of APIs and polymorphism studies to support pharmaceutical development and manufacturing teams.

Total Funding Amount:

2M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Illkirch, Alsace, France

Founded Date:

2002-01-01

Contact Email:

info(AT)novalix-pharma.com

Founders:

Dino Moras, Jean-Paul Renaud, Stephan Jenn

Number of Employees:

51-100

Last Funding Date:

2024-08-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai